Cart (0 Items)
Your cart is currently empty.
View Products 
               
               
               
              | Size | 100ug, 1MG | 
|---|---|
| Isotype | IgG4, kappa | 
| Brand | ProteoGenix | 
| Product type | Primary Antibodies | 
| Clonality | Monoclonal Antibody | 
| Expression system | Mammalian cells | 
| Applications | Elisa, WB | 
| Product name | Pepinemab Biosimilar - Anti-SEMA4D mAb - Research Grade | 
|---|---|
| Source | CAS 2097151-87-4 | 
| Species | Humanized | 
| Expression system | Mammalian cells | 
| Purity | >85% | 
| Buffer | PBS buffer PH7.5 | 
| Delivery condition | Blue ice (+4°C) | 
| Delivery lead time in business days | 3-5 days if in stock; 3-5 weeks if production needed | 
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed | 
| Storage condition | store at -80°C | 
| Brand | ProteoGenix | 
| Aliases /Synonyms | Pepinemab ,VX-15,VX15/2503,SEMA4D,anti-SEMA4D | 
| Reference | PX-TA1382 | 
| Note | For research use only. Not suitable for human use. | 
| Isotype | IgG4-kappa | 
| Clonality | Monoclonal Antibody | 
Pepinemab is investigated for the treatment of Resectable Stage IIIB-D Melanoma with or without Ipilimumab and/or Nivolumab.
 
                Pepinemab Biosimilar - Anti-SEMA4D mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Related products
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.